Perrigo surprised its investors Thursday with better than expected results and announced it was selling its API business for $110 million.

German regulators have pulled the manufacturing certificate for Dr. Reddy’s formulation plant in India.

Bristol-Myers Squibb is selling a clinical materials manufacturing facility in Washington to Seattle Genetics, which will keep the 72 workers.

Boehringer Ingelheim saw a significant rise in sales in the first half of the year, in part from a healthy jump in its contract manufacturing operations.

GlaxoSmithKline plans to unload some marginal businesses and make other cuts that it says will cost about 320 manufacturing jobs in its home country.

India’s Alembic Pharma said the facility will manufacture 60 million tablets and capsules and about 20 million vials of liquid concentrates.

The FDA has issued a warning letter to India's Vista Pharmaceuticals after it found it using corroded equipment.

AGC Asahi Glass, which bought CMC Biologics this year, will make its Seattle, Washington, area operation the headquarters of its drug business.